Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Belt

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer|September 1, 1979
Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancerR J Belt, R Stephens
Cancer Treatment Reports|September 1, 1981
Phase I study on bruceantin administered on a weekly scheduleJ Liesmann, R J Belt, C D Haas, et al.
Cancer|June 1, 1983
Phase I trial of Indicine-N-Oxide on two dose schedulesS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|May 1, 1981
Phase I evaluation of IMPY in a twice weekly scheduleC D Haas, U Joseph, R J Belt, et al.
Cancer|August 1, 1980
Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronizationR J Belt, C D Haas, J Kennedy, et al.
Cancer Treatment Reports|January 1, 1980
Cholestatic jaundice associated with chlorozotocinR J Belt, D McGregor, C D Haas, et al.
JAMA|June 16, 1978
Incidence of hemorrhagic complications in patients with cancerR J Belt, C Leite, C D Haas, et al.
Investigational New Drugs|January 1, 1984
Phase I evaluation of AT-125 single dose every three weeksS Taylor, R J Belt, U Joseph, et al.
Cancer|December 1, 1980
Phase I evaluation of chlorozotocin: single dose every six weeksS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|November 1, 1979
Phase I study of anguidine administered weeklyR J Belt, C D Haas, U Joseph, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer|September 1, 1979
Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancerR J Belt, R Stephens
Cancer Treatment Reports|September 1, 1981
Phase I study on bruceantin administered on a weekly scheduleJ Liesmann, R J Belt, C D Haas, et al.
Cancer|June 1, 1983
Phase I trial of Indicine-N-Oxide on two dose schedulesS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|May 1, 1981
Phase I evaluation of IMPY in a twice weekly scheduleC D Haas, U Joseph, R J Belt, et al.
Cancer|August 1, 1980
Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronizationR J Belt, C D Haas, J Kennedy, et al.
Cancer Treatment Reports|January 1, 1980
Cholestatic jaundice associated with chlorozotocinR J Belt, D McGregor, C D Haas, et al.
JAMA|June 16, 1978
Incidence of hemorrhagic complications in patients with cancerR J Belt, C Leite, C D Haas, et al.
Investigational New Drugs|January 1, 1984
Phase I evaluation of AT-125 single dose every three weeksS Taylor, R J Belt, U Joseph, et al.
Cancer|December 1, 1980
Phase I evaluation of chlorozotocin: single dose every six weeksS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|November 1, 1979
Phase I study of anguidine administered weeklyR J Belt, C D Haas, U Joseph, et al.
Pageof 3